West Tower Group’s Anterix ATEX Stock Holding History

West Tower Group’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-252	Closed	-$7.99K	–	610
2023 Q2	$7.99K	Buy	+252	New	+$8.14K	0.01%	457

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

West Tower Group's ATEX Position: Q3 2023 in Review

West Tower Group sold out of Anterix (ATEX) in Q3 2023, closing a stake of 252 shares — an estimated $7.99K sold.

West Tower Group first reported a position in ATEX in Q2 2023 and held it in 1 quarter. The position peaked at $7.99K in Q2 2023. 98 funds tracked by Wall St. Rank hold ATEX as of Q3 2023.

West Tower Group reported no remaining Anterix position as of Q3 2023 after selling out during the quarter.
West Tower Group sold 252 Anterix shares in Q3 2023, an estimated $7.99K.
West Tower Group first reported a position in Anterix in Q2 2023 and held it in 1 quarter.
West Tower Group's Anterix position peaked at $7.99K in Q2 2023.
98 funds tracked by Wall St. Rank held Anterix as of Q3 2023.

Based on West Tower Group's 13F filing for Q3 2023, filed 14 Nov 2023.